跳至主要内容
临床试验/TCTR20160526001
TCTR20160526001尚未招募4 期

Effectiveness & Efficiency of STEPwise Approach of Smoking Cessation System in Thailand (STEP trial)

Thai Health Professional Alliance Against Tobacco (ThaiPAT)0 个研究点目标入组 3,397 人开始时间: 2016年5月26日最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
3,397

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 Years 至 100 Years(—)
性别
All

入选标准

  • •20 years old or more
  • •Smoke at least 10 cigarettes regularly per day.
  • •Addicted to Nicotine at a moderate level with more than 4 points in Fagerstrom Test of Nicotine Dependence (FTND).
  • •Desire to quit.
  • •Agree to receive smoking cessation service at a clinic if they are unable to quit smoking by using service in the community.
  • •Agree to receive therapy and medication and all the steps provided by the research programme.
  • •Willing to be followed up for 12 months.
  • •Not been treated with any therapy within the last 3 months.
  • •Not a chronic alcoholic (AUDIT score ≤7).

排除标准

  • •Have severe Coronary Artery Disease.
  • •Pregnant or planning to become pregnant or breastfeeding.
  • •Have a history of any kind of allergy to tobacco cessation drugs.
  • •Use drugs for antidepression in the monoamine oxidase inhibitors (MAOIs) group.
  • •Have a history of liver disease or kidney disease.
  • •Have a history of epilepsy, schizophrenia or chronic depression.
  • •Have a history of cancer, except for skin cancer that is treated.
  • •Have dangerous hypertension (Systolic blood pressure>150mmHg or diastolic blood pressure>95 mmHg.
  • •Have a severe congenital disease that is unstable within the last six months.
  • •Have BMI> 38 or <15.
  • •Have a history of severe emphysema.
  • •Are chronic alcoholics (the AUDIT score> 7) or use other addictive substances.
  • •Refuse an initial interview and physical examination.
  • •Use an electric cigarette, Baraku and electric Baraku.
  • •ECG shows serious cardiac arrhythmias (malignant arrhythmia).

研究者

发起方
Thai Health Professional Alliance Against Tobacco (ThaiPAT)

相似试验